A crossover study after oral and intravenous administration of theophylline in male volunteers (absolute bioavailability of Afonilum tablets)
- PMID: 6885204
A crossover study after oral and intravenous administration of theophylline in male volunteers (absolute bioavailability of Afonilum tablets)
Abstract
Seven normal male volunteers received an injection of 208 mg theophylline-anhydride (Solosin) each for 4 min, and a 225-mg single oral dose (Afonilum) on separate occasions. The concentration of unchanged theophylline was analyzed over a 24-h period in plasma and over a 48-h period in urine, after both dosage forms. A two-compartment model was required to describe the i.v. plasma concentration-time course in all seven subjects. A one-compartment model sufficed to account for the decay of the oral plasma concentrations in five of the subjects. The mean plasma t 1/2 after i.v. dosing was 6.5 h (3.5-9 h), and the mean plasma t 1/2 after oral doses was 5.9 h (3-8.3 h). The calculated mean total of 23% (11-70%) of the i.v. dose was excreted in the urine, and the mean total excretion after the oral dose was 15% (7-44%). The absolute bioavailability of Afonilum was 108 +/- 11%.
Similar articles
-
A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets.Arzneimittelforschung. 1984;34(1):92-5. Arzneimittelforschung. 1984. PMID: 6538428
-
Pharmacokinetics of etofylline after intravenous and oral administration to humans.Int J Clin Pharmacol Ther Toxicol. 1981 Jul;19(7):310-3. Int J Clin Pharmacol Ther Toxicol. 1981. PMID: 7263108
-
Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.Methods Find Exp Clin Pharmacol. 1994 Nov;16(9):651-60. Methods Find Exp Clin Pharmacol. 1994. PMID: 7746027 Clinical Trial.
-
Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.Int J Clin Pharmacol Ther Toxicol. 1981 May;19(5):223-7. Int J Clin Pharmacol Ther Toxicol. 1981. PMID: 7251238
-
Dose-dependent kinetics of theophylline.J Allergy Clin Immunol. 1986 Oct;78(4 Pt 2):723-7. doi: 10.1016/0091-6749(86)90052-7. J Allergy Clin Immunol. 1986. PMID: 3534053 Review.
Cited by
-
Estimation of drug absorption rates using a deconvolution method with nonequal sampling times.J Pharmacokinet Biopharm. 1986 Apr;14(2):213-25. doi: 10.1007/BF01065261. J Pharmacokinet Biopharm. 1986. PMID: 3746639
-
Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.Clin Pharmacokinet. 1995 Apr;28(4):287-314. doi: 10.2165/00003088-199528040-00003. Clin Pharmacokinet. 1995. PMID: 7648758 Review.
-
A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.Clin Pharmacokinet. 1984 Mar-Apr;9(2):95-135. doi: 10.2165/00003088-198409020-00001. Clin Pharmacokinet. 1984. PMID: 6370542 Review.
-
An inequality-constrained least-squares deconvolution method.J Pharmacokinet Biopharm. 1989 Apr;17(2):269-89. doi: 10.1007/BF01059031. J Pharmacokinet Biopharm. 1989. PMID: 2677315 Review.